Cross-site scripting (XSS) vulnerability in IBM Marketing Platform 9.1 before FP2 allows remote authenticated users to inject arbitrary web…

published 2014-06-28 12y ago modified 2026-06-17 4mo ago also EUVD-2013-6136

cvss: 3.5; version 2.0, NVD
cisa kev: Not listed; not in CISA's catalog
epss: 0.8%; EPSS 0.8% chance of exploitation in 30 days, percentile 55%
public exploits: 0; none known

Cross-site scripting (XSS) vulnerability in IBM Marketing Platform 9.1 before FP2 allows remote authenticated users to inject arbitrary web script or HTML via unspecified vectors.

Is CVE-2013-6310 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.

Check with Fencer

Exploit prediction

0.76% chance of exploitation in the next 30 days, higher than 55% of all scored CVEs (FIRST EPSS, 2026-11-09).

CVSS scores

assigned by	version	score	vector
NVD	2.0	3.5	AV:N/AC:M/Au:S/C:N/I:P/A:N

Classification

Weakness

CWE-79 Improper Neutralization of Input During Web Page Generation

References

www-01.ibm.com /support/docview.wss?uid=swg21676688
vendor-advisory
exchange.xforce.ibmcloud.com /vulnerabilities/88560
vdb-entry

Sources

CVE List CVE-2013-6310
NVD CVE-2013-6310

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.